For the quarter ending 2026-03-31, FENC has $71,822K in assets. $34,147K in debts. $40,179K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 40,179 | 21,947 | 18,705 | |
| Accounts receivable, net | 18,762 | 19,343 | 17,502 | |
| Prepaid expenses | 3,461 | 1,399 | 1,421 | |
| Inventory | 1,856 | 2,477 | 2,201 | |
| Other current assets | 2,622 | 898 | 965 | |
| Total current assets | 66,880 | 46,064 | 40,794 | |
| Non-current accounts receivable, net | 4,251 | 2,454 | 3,314 | |
| Other non-current assets, net of amortization | 691 | 743 | 768 | |
| Total non-current assets | 4,942 | 3,197 | 4,082 | |
| Total assets | 71,822 | 49,261 | 44,876 | |
| Accounts payable | 6,281 | 5,866 | 5,941 | |
| Accrued liabilities | 3,057 | 3,701 | 2,225 | |
| Contract liability - current | 248 | 248 | 248 | |
| Total current liabilities | 9,586 | 9,815 | 8,414 | |
| Term loan | - | 18,206 | 18,206 | |
| Pik interest | - | 1,271 | 1,271 | |
| Debt discount | - | 100 | 113 | |
| Contract liability - long-term | 24,561 | 24,561 | 24,561 | |
| Total non-current liabilities | 24,561 | 43,938 | 43,925 | |
| Total liabilities | 34,147 | 53,753 | 52,339 | |
| Common stock, no par value unlimited shares authorized 34,541 shares issued and outstanding (2025 - 34,163) | 191,229 | 147,652 | 146,165 | |
| Additional paid-in capital | 74,424 | 71,249 | 69,127 | |
| Accumulated deficit | -229,221 | -224,636 | -223,998 | |
| Accumulated other comprehensive income | 1,243 | 1,243 | 1,243 | |
| Total shareholders' equity/(deficit) | 37,675 | -4,492 | -7,463 | |
| Total liabilities and shareholders' equity/(deficit) | 71,822 | 49,261 | 44,876 | |
FENNEC PHARMACEUTICALS INC. (FENC)
FENNEC PHARMACEUTICALS INC. (FENC)